Dow Pharmaceuticals

Dow Pharmaceutical Sciences was a specialty pharmaceutical company focused on the development of topical drug products for dermatology. The company provided a full range of product development services, including formulation, analytical chemistry, and clinical research, while also developing its own proprietary pipeline. It was best known for its expertise in semi-solid dosage forms and was acquired by Valeant Pharmaceuticals in 2008 to bolster their dermatological portfolio. Their successful development efforts led to the FDA approval of key products such as Aczone and Ziana. Today, the company's legacy continues as a core component of Bausch Health's dermatology business.